5 Myths I Hear in M&A Risk Conversations And Why They Matter

When I speak with CFOs, deal teams, and portfolio managers mid-transaction, there are a few risk beliefs that come up repeatedly. They’re not always wrong, but they do need pressure-testing, especially in today’s environment, where the stakes are high, good companies are scarce, and due diligence windows are shrinking.

This isn’t about sounding the alarm unnecessarily, rather, recognising financial risk with clarity and doing so early enough to act. In the UK alone, 25,158 companies entered insolvency in 2024, according to official government data. A fair number of those were bought or backed by someone along the way. Financial failures of acquired companies cost private equity and lenders billions globally.

Spotting early distress, seeing past surface-level filings, and understanding what the numbers are really saying has never been more essential, especially in M&A where timing is everything.

This article is for risk professionals who spend time in the complex stages of deal-making. If you’re the person expected to size up targets quickly, make sense of patchy filings, and avoid deals that fall over after close, I’ve written this with you in mind. These are myths I keep hearing from clients and the market, and some of the realities I’ve seen play out up close.

Myth 1: Due diligence means you’ve covered your risk

There’s a quiet confidence that sets in once initial diligence starts in an M&A process. External accountants are combing through the books, the internal model is built, you’ve got your red flags list.

Most of the risk conversations I’m part of start well before a deal gets formalised, often weeks ahead of any diligence work. This isn’t about trying to replace forensic reviews. It’s about helping deal teams get ahead, asking the right questions early, spotting signs of stress in filings or inconsistencies in the narrative, and surfacing concerns while there’s still time to act. Ideally, that starts long before a virtual data room is even mentioned.

And the truth is, most deals will never have perfect visibility. Founders can delay filings; accounts can be dressed up; Directors can be linked to dissolved firms through subtle ownership paths that don’t show up in a PDF export. Diligence might confirm your thesis, or it might confirm the version of the story the seller wants to tell.

Myth 2: If the company looks fine now, there’s no urgency

I hear this a lot when someone’s found a quiet business they like. Small, profitable, steady cash flows. Maybe the accounts are a year old, but nothing seems obviously wrong.

Here’s the catch: distress rarely shouts. In fact, one of the biggest signals we see ahead of company failure is silence. Delayed filings, missed changes, no news when there should be some. By the time a firm drops below a viable health score, the red flags have usually been there for months.

Our H Score®, for example, has historically flagged companies with high accuracy for financial distress within a three-year window when their score drops below 25. That kind of early warning only matters if you’re paying attention.

We once flagged a £20m-turnover target because its retained earnings profile didn’t align with the growth narrative. It reminded me of a case we saw recently with BOSHHH LTD. Their H Score® was just 5 out of 100 in 2023, dropping to 4 the following year – well inside the Warning Area, where failure becomes statistically likely. Despite no revenue, their liabilities surged to £459k, with four unsatisfied CCJs and over £3 million owed to unsecured creditors. A bank took a heavy six-figure hit. The signs – low score, poor liquidity, legal pressure – were all visible in the data. It’s a reminder that what looks steady at a glance can be structurally weak underneath.

Myth 3: More data means less risk

It’s tempting to think if you just pull more sources, you’ll get to the truth. But raw data is not insight. And at worst, it can create false confidence.

The strongest deal teams I know aren’t just scraping LinkedIn and Companies House. They’re building clean, structured profiles of companies using tools like our highly popular Data Builder, segmenting by health, stability, and financial characteristics that align to strategy.

And they’re asking smart questions: Why has this director moved between three entities in five years? Why does this supplier’s financial profile look oddly like its competitor’s? When was this group structure last updated?

More data doesn’t help if it’s fragmented or misleading. What matters is whether it helps you connect dots faster than the other side.

Myth 4: Fraud is rare in these kinds of targets

Sometimes people think fraud is a public sector issue, or something you only worry about when buying distressed assets. But some of the more subtle cases we’ve seen have come from profitable, growing businesses.

It’s not always criminal. Sometimes it’s aggressive accounting. Sometimes it’s one director hiding a prior disqualification behind a near-match name. In some cases, we’ve seen evidence of filings being copied and pasted, year after year, to keep up appearances.

Our platform recently flagged a company where four years of accounts had identical wording, layout, and even punctuation. A deeper look showed they were duplicating filings from a dissolved sister firm. That’s not just sloppy, it’s a signal.

Myth 5: We’ll pick it up once we’re further along

The team likes the asset, the numbers work, and it’s early. So the plan is to run basic checks now and go deeper later.

But later doesn’t always come. The deal heats up. Another bidder enters. The founder goes quiet. And suddenly you’re in exclusivity with a company you only half understand.

The best investors I know don’t leave risk for later. They triage early. They put targets on monitoring lists to highlight critical alerts during the process, and use scenario tools to see how close to the edge a business really is.

What good risk insight really does

In M&A, the biggest returns often come from seeing what others overlook. That takes more than data. It takes judgement, a trained eye, and a process that gives risk a seat at the table from day one.

The best teams I work with are already monitoring targets using our live alerting tools, watching for late filings – or more subtle changes like ARD changes, director disqualifications, and cash flow crunch indicators that signal when a business might be heading for trouble. They know that even minor shifts in financial health can accumulate into major exposure if ignored. They build watchlists based on H Score® thresholds, set rules to flag financial health declines, and check for inconsistencies in revenue recognition or balance sheet growth.

They’re also asking more from their data. What has happened, yes, but also what’s likely to happen next. Our Stress Testing tool, for example, lets you model how a business might perform under stress – useful if you’re about to inherit their cash flow forecast.

That’s the kind of judgement that only comes from doing the work. And in my opinion, it’s still the most reliable form of due diligence there is.